Skip to Main Content

Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source.


Funding

The Vera and Joseph Dresner Foundation MDS Research Fund
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).

The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards

Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>

Fast Funding for COVID-19 Science

If you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, we invite you to apply for a Fast Grant.

Deadline: Fast Grant decisions are made in under 48 hours. Apply Now!

Apply for a Fast Funding grant now>>


Department of Defense Lung Cancer Research Program

The FY20 Defense Appropriations Act provides funding to the Department of Defense Lung Cancer Research Program (LCRP) to support innovative, high-impact lung cancer research. Pre-application and application deadlines will be available when the Program Announcements are released.

Learn more about the DoD Lung Award>>

DoD Peer Reviewed Cancer Research Program Funding Opportunities

The FY20 Defense Appropriations Act provides funding to the DoD Peer Reviewed Cancer Research Program (PRCRP) to support innovative, high-impact cancer research.

  • Virtual Cancer Center Director Award – Letter of Intent due July 30, 2020
  • Career Development Award – Fellow Option – Letter of Intent due July 30, 2020
  • Career Development Award – Cancer Center Scholar Option – Letter of Intent due July 30, 2020
  • Behavioral Health Science Award – Letter of Intent due July 30, 2020
  • Translational Team Science Award – Letter of Intent due July 30, 2020

Learn more about the DoD PRCRP funding>>


Damon Runyon Cancer Research Foundation Dale F. Frey Award for Breakthrough Scientists

Damon Runyon Fellows are eligible to apply in the fourth year of their Fellowship. This FO enables them to complete their training under the mentorship of a leading senior scientist and encourages them to follow their own bold ideas.

Application Deadline: July 15, 2020


DoD FY20 Kidney Cancer Research Program

The KCRP focuses on the issues regarding prevention, detection, treatment, and the long-term effects of treatment for kidney cancer for Service Members, Veterans, their families, and the American public.

Early Career Investigator Award - Letter of Intent Due: August 5, 2020
Concept Award - Letter of Intent Due: July 15, 2020
Translational Research Partnership Award - Letter of Intent Due: August 5, 2020



FY20 Ovarian Cancer Research Program Proteogenomics Research Award

This Research Award supports the use of proteomics and/or genomics to explore new concepts or theories in ovarian cancer. The award is intended to support the genomic and/or transcriptomic and/or proteomic analysis of currently available clinical specimens with a focus on answering biologic and pathophysiologic questions of clinical relevance in ovarian cancer.

Letter of Intent Due: July 16, 2020



Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43)

The purpose of this FOA is to establish an institutional program for mentored training in global cancer research.

Application Deadline: July 24, 2020


Mark Foundation for Cancer Research ASPIRE Award

This award is designed to enable innovative approaches to solving high-impact problems in cancer research that tend to fall outside the scope of other funding opportunities.

Application Deadline: July 31, 2020


Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and AYA Cancer Survivors (R01 and R21)

Through this FOA the NCI invites applications describing research focused on improving care and health-related quality of life for childhood, and adolescent and young adult cancer survivors.

Application Deadline: July 31, 2020

NCCN Pfizer Axitinib Request for Proposals (RFP)

NCCN and Pfizer are collaborating to offer a new grant opportunity seeking proposals to support NCCN Member Institution faculty utilizing axitinib. The overall aim is to develop innovative trials that will evaluate the role of axitinib in the treatment of melanoma, hepatocellular carcinoma, and colorectal cancer.

Application Deadline: August 12, 2020

Learn more about the NCCN/Pfizer RFP>>


Lasker Clinical Research Scholars Program (Si2/R00)

This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers.

Application Deadline: August 28, 2020

DoD Prostate Cancer Research Program Funding Opportunities for Fiscal Year 2020 (FY20)

The FY20 Defense Appropriations Act provides funding to the Department of Defense Prostate Cancer Research Program (PCRP) to support innovative, high-impact prostate cancer research. The mission of the FY20 PCRP is to fund research that will lead to the elimination of death from prostate cancer and enhance the well-being of Service members, Veterans, and all the men and their families who are experiencing the impact of the disease.

Idea Development Award– LOI Due: August 27, 2020

Learn more about the DoD Prostate FY20 funding>>


NCCN Pfizer Biosimilars Request for Proposals (RFP)

The intent of this RFP is to encourage NCCN Member Institutions and non-NCCN Member Institutions to submit proposals describing concepts and ideas that develop and validate enduring approaches that improve the safe and efficient adoption of biosimilars in oncology.

Letter of Intent Due: September 9, 2020


3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2)

Through this FOA, the NCI, as a part of its Beau Biden Cancer Moonshot Initiative, invites submission of applications requesting support for projects that will accelerate cancer research.

Application Deadline: November 9, 2020

Learn more about the NCI UH2>>


Alex's Lemonade Stand RUNX1 Early Career Investigator Grant

This grant is a 3-year award designed to fund research in strategies leading to the development of therapies to prevent the transition from pre-leukemia to leukemia for patients with RUNX1-FDP.

Application Deadline: December 16, 2020

Learn more about the RUNX1 Grant>>